Abstract:4114 Background: Liver transplant (LT) contributes to the cure of hepatocellular carcinoma (HCC) by extending the conventional surgical margin, while removing the concurrent tumor-favoring conditions of the diseased liver. Over the past two decades, HCC has emerged as a preferable indication for LT, accounting for 22-45% of the cases globally. However, despite the stringent selection criteria, recurrence still occurs in a substantial proportion of patients, leaving 10-13 months of median survival after tumor relapse. To address this challenge, a thorough exploration of molecular mechanism behind HCC recurrence after LT is required. Here, for the first time, we performed a comprehensive analysis to depict the evolving and unique ecosystem of HCC in the context of LT and immunosuppressant (IS) administration. Methods: We retrospectively reviewed our biobank and collected 91 paired (primary tumors (PT) from the explant after LT and relapsed tumors (RT) from hepatectomy) FFPE tumor samples from 15 patients for whole exome sequencing (WES). Also, from Jan 2021, we prospectively collected surgical tumor specimens and their adjacent non-tumor tissues from 15 primary and 6 post-LT intrahepatic recurrence patients for single-cell RNA sequencing. Moreover, 6 paired samples from 3 patients were used for spatial transcriptomic analysis. Results: By analysing WES data, we confirmed that RT samples represent recurrent, instead of de novo tumors. Also, the phylogenetic analysis demonstrated strong clonal relationship between PT and RT based on shared SNVs. As to mutation landscape differences of PT and RT, we identified a significantly enriched mutation panel from RT, including MUC16, FAT3, APOB, COL6A3 and POTEC. And the accuracy of this panel for post-LT HCC recurrence surveillance using plasma derived cfDNA sequencing has been preliminarily validated in a prospective cohort of 17 patients. From the single-cell profiling, distinct immune microenvironment between PT and RT is identified. As predicted, proliferating T cells are decreased in RT due to IS. Pseudotime analysis of T cells revealed that T cells from PT mainly distribute at the terminal end of cytotoxic stage whereas T cells from RT mostly represent a naïve state, further confirming the T cell blocking effect of IS. In terms of myeloid cells, we surprisingly found that FOLR2+ tumor associated macrophages, which is conventionally considered as a favorable prognosis factor, is increased in RT. Spatial transcriptomics and IHC also confirmed their active interplay with tumor cells at invasive margin. We postulate that such increase might be a result of the healthy nature of liver graft. Conclusions: Our comprehensive dissection of the HCC ecosystem provides deeper insights into the tumor relapse after LT. Targeting novel mutations and strengthen the antigen presenting process between increased TAM and disabled T cells can be the future direction in this field. Clinical trial information: NCT04506398 .

Impact of Deviated Balance of Regulatory and Cytotoxic T Cells on Release and Reseeding of Circulating Tumor Cells in Hepatocellular Carcinoma.

Infiltrating Regulatory T Cells Promote Invasiveness of Liver Cancer Cells Via Inducing Epithelial-Mesenchymal Transition

Intratumoral Balance of Regulatory and Cytotoxic T Cells is Associated with Prognosis of Hepatocellular Carcinoma after Resection

Intratumoral Regulatory T Cells Alone or in Combination with Cytotoxic T Cells Predict Prognosis of Hepatocellular Carcinoma after Resection.

Limited Predictive or Prognostic Role of Tumor-Infiltrating Tissue-Resident Memory CD8 T Cells in Patients with Hepatocellular Carcinoma Receiving Immunotherapy

Comprehensive Analysis of the Immunosuppressive Function of Regulatory T Cells in Human Hepatocellular Carcinoma Tissues

Intratumoral Regulatory T Cells with Higher Prevalence and More Suppressive Activity in Hepatocellular Carcinoma Patients

Impact of increased CD4+ CD25+ FOXP3+ regulatory T cells on tumor recurrence in liver transplantation for hepatocellular carcinoma

Increased Frequency of CD4+CD25highFoxP3+ Regulatory T Cells in Patients with Hepatocellular Carcinoma

Clinical Prognostic Value of CD4+CD25+FOXP3+regulatory T Cells in Peripheral Blood of Barcelona Clinic Liver Cancer (BCLC) Stage B Hepatocellular Carcinoma Patients.

Selective Recruitment of Regulatory T Cell Through CCR6-CCL20 in Hepatocellular Carcinoma Fosters Tumor Progression and Predicts Poor Prognosis.

Association of Phenotypic Transformation of Circulating Tumor Cells and Early Recurrence in Patients with Hepatocellular Carcinoma Following Liver Transplantation

Regulatory T Cell Depletion Enhances Tumor Specific CD8 T-cell Responses, Elicited by Tumor Antigen NY-ESO-1b in Hepatocellular Carcinoma Patients, in Vitro

Association of Intratumoral Regulatory T-cell Accumulation in Patients with Hepatocellular Carcinoma (HCC) with Poor Survival: Effect of Autologous Dendritic Cell Immunotherapy on Selective Reduction of Regulatory T Cells and Survival.

Integrative study reveals the prognostic and immunotherapeutic value of CTCs/CTMs -related prognostic signature in Hepatocellular carcinoma

Dissecting the Spatial Heterogeneity of Single CTCs Reveals Immune Evasion Through MAX Regulated CCL5 Overexpression in Hepatocellular Carcinoma

Analysis of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Recurrence Following Liver Transplantation.

Low Counts of Γδ T Cells in Peritumoral Liver Tissue Are Related to More Frequent Recurrence in Patients with Hepatocellular Carcinoma after Curative Resection.

[Clinical Significance of Regulatory T Cells Proportion in the Peripheral Blood and Tumor Tissue in Primary Hepatocellular Carcinoma].

The immune-metabolic crosstalk between CD3+C1q+TAM and CD8+T cells associated with relapse-free survival in HCC

Tracking the Evolving Ecosystem of Recurrent Hepatocellular Carcinoma after Liver Transplantation